Table 6.
Medication compliance | |||
---|---|---|---|
Low group (n = 29) | High group (n = 63) | P | |
n (%) | n (%) | ||
Characteristics | |||
Age (≥65 years) | 17 (58.6) | 43 (68.3) | 0.480 |
Sex (female) | 6 (20.7) | 15 (23.8) | 0.796 |
Dialysis period (≥median) | 14 (48.3) | 33 (52.4) | 0.823 |
Causative disease (kidney disease) | 11 (37.9) | 35 (55.6) | 0.178 |
EQ-5D | |||
Utility value (≥standard value) | 9 (31.0) | 29 (46.0) | 0.254 |
KDQOL-SF | |||
Kidney disease-specific scale | |||
Symptoms (≥mean) | 15 (51.7) | 40 (63.5) | 0.361 |
Effect of kidney disease (≥mean) | 15 (51.7) | 34 (54.0) | 1.000 |
Burden of kidney disease (≥mean) | 18 (62.1) | 29 (46.0) | 0.182 |
Work status (≥mean) | 7 (24.1) | 12 (19.0) | 0.589 |
Cognitive function (≥mean) | 21 (72.4) | 52 (82.5) | 0.280 |
Quality of social interaction (≥mean) | 20 (69.0) | 46 (73.0) | 0.804 |
Sleep (≥mean) | 11 (37.9) | 39 (61.9) | 0.043* |
Non-health related QOL scale | |||
Social support (≥mean) | 20 (69.0) | 33 (52.4) | 0.175 |
Dialysis staff encouragement (≥mean) | 19 (65.5) | 31 (49.2) | 0.179 |
Patient satisfaction (≥mean) | 14 (48.3) | 21 (33.3) | 0.248 |
Summary score | |||
PCS (≥50) | 4 (13.8) | 13 (20.6) | 0.568 |
MCS (≥50) | 25 (86.2) | 51 (81.0) | 1.000 |
RCS (≥50) | 16 (55.2) | 38 (60.3) | 0.656 |
Medication management situation | |||
Occupation (employed) | 17 (58.6) | 42 (66.7) | 0.489 |
Medication storage (medication bag) | 8 (27.6) | 20 (31.7) | 0.809 |
Medication storage state (sheet) | 18 (62.1) | 40 (63.5) | 1.000 |
Knowledge of effects (Know a certain amount or above) | 18 (62.1) | 34 (54.0) | 0.505 |
Knowledge of side effects (Know a certain amount or above) | 7 (24.1) | 13 (20.6) | 0.787 |
Number of types of medication (≥7) | 23 (79.3) | 53 (84.1) | 0.567 |
Frequency of administration (≥6 times/day) | 13 (44.8) | 37 (58.7) | 0.262 |
P < 0.05. QOL, Quality of life; EQ-5D, EuroQol 5 dimension; PCS, Physical component summary; MCS, Mental component summary; RCS, Role-social component summary.